Evidence map›Paper›PMID 37386345›Full record

ArticleDrugs & aging2023

Utility of Big Data to Explore Medication Adherence in Māori and Non-Māori Community-Dwelling Older Adults with Heart Failure in Aotearoa New Zealand: A Cross-sectional Study.

Joanna Hikaka, Rebecca Abey-Nesbit, Brendon McIntosh, Philip J Schluter, Prasad S Nishtala, Richard Scrase, Hamish A Jamieson

Open access · hybridAbstract read
In one paragraph

Article in Drugs & aging, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.5field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 3 countries.

Joanna HikakaFacility of Medicine and Health Sciences, University of Auckland, Auckland, New Zealand.
Rebecca Abey-NesbitDepartment of Medicine, University of Otago, Christchurch, New Zealand.
Brendon McIntoshDepartment of Medicine, University of Otago, Christchurch, New Zealand.
Philip J SchluterTe Kaupeka Oranga/Faculty of Health, Te Whare Wānanga o Waitaha/University of Christchurch, Christchurch, 8041, New Zealand.
Prasad S NishtalaDepartment of Life Sciences, Centre for Therapeutic Innovation, University of Bath, Bath, United Kingdom.
Richard ScraseDepartment of Medicine, University of Otago, Burwood Campus, PO box, 4345, Christchurch, New Zealand.
Hamish A JamiesonDepartment of Medicine, University of Otago, Burwood Campus, PO box, 4345, Christchurch, New Zealand. Hamish.jamieson@otago.ac.nz.
University of Otago · NZStructural Timber Innovation Company (New Zealand) · NZUniversity of Auckland · NZUniversity of Bath · GBUniversity of Queensland · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMedication adherence improves morbidity and mortality-related outcomes in heart failure, and knowledge of patterns of medication adherence supports patient and clinician decision-making. Routinely collected national data facilitate the exploration of medication adherence and associated factors in older adults with heart failure, including the association between ethnicity and adherence. There are known inequities in access to medicines between Māori (Indigenous People of Aotearoa New Zealand) and non-Māori, yet ethnic variation in medicines adherence in community-dwelling older adults with heart failure has not been explored.

objectiveHere we identify medication adherence rates for community-dwelling older adults diagnosed with heart failure and differences in adherence rates between Māori and non-Māori.

methodsCross-sectional analysis of interRAI (comprehensive standardised assessment) data in a continuously recruited national cohort from 2012 to 2019.

resultsOverall, 13,743 assessments (Māori N = 1526) for older community-dwelling adults with heart failure diagnoses were included. The mean age of participants was 74.5 years [standard deviation (SD) 9.1 years] for Māori and 82.3 years (SD 7.8 years) non-Māori. In the Māori cohort, 21.8% did not adhere fully to their medication regimen, whereas in the non-Māori cohort, this figure was 12.8%. After adjusting for confounders, the Māori cohort were more likely to be medication non-adherent than non-Māori [prevalence ratio 1.53, 95% confidence interval (CI) 1.36-1.73].

conclusionsThere was a significant disparity between Māori and non-Māori concerning medication adherence. Given the international use of the interRAI-HC assessment tool, these results have significant transferability to other countries and allow the identification of underserved ethnic groups for which culturally appropriate interventions can be targeted.

Indexed as

Heart FailureIndependent LivingAgedBig DataCross-Sectional StudiesHumansMedication AdherenceNew Zealand

Identifiers

PMID37386345
PMCPMC10450015
OpenAlexW4382601445

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.